|
2014
|
Invention
|
Application of mrna for use as a therapeutic against tumour diseases. The present invention relat... |
|
|
Invention
|
Combination of vaccination and inhibition of the pd-1 pathway. The present invention relates to a... |
|
2013
|
Invention
|
Artificial nucleic acid molecules for improved protein or peptide expression. The invention relat... |
|
|
Invention
|
Artificial nucleic acid molecules. The invention relates to an artificial nucleic acid molecule c... |
|
|
Invention
|
Artificial nucleic acid molecules comprising a 5'top utr. The invention relates to an artificial ... |
|
|
Invention
|
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen. The prese... |
|
2012
|
Invention
|
Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (... |
|
|
Invention
|
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenyla... |
|
|
Invention
|
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenyl... |
|
|
Invention
|
Negatively charged nucleic acid comprising complexes for immunostimulation. The present invention... |
|
|
Invention
|
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein ... |
|
2011
|
Invention
|
Combination of vaccination and inhibition of mhc class restricted antigen presentation. The prese... |
|
|
Invention
|
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and... |
|
|
Invention
|
Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof... |
|
|
Invention
|
Vaccination in elderly patients. The present invention relates to vaccines comprising at least on... |
|
|
Invention
|
Vaccination in newborns and infants. The present invention relates to vaccines comprising at leas... |
|
|
Invention
|
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged wi... |
|
2010
|
Invention
|
Combination of vaccination and inhibition of mhc class i restricted antigen presentation. The pre... |
|
|
Invention
|
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids. The... |
|
2009
|
Invention
|
Lyophilization of nucleic acids in lactate-containing solutions. The present invention is directe... |
|
|
Invention
|
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids. T... |
|
|
Invention
|
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunost... |
|
|
Invention
|
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, ... |
|
|
Invention
|
Nucleic acids comprising formula (nuglxmgnnv)a and derivatives thereof as an immunostimulating ag... |
|
2008
|
Invention
|
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc). The present... |
|
|
Invention
|
Composition for treating prostate cancer (pca). The present invention relates to an active (immun... |
|
|
Invention
|
Complexes of rna and cationic peptides for transfection and for immunostimulation. The present in... |
|
|
Invention
|
Modified (m)rna for suppressing or avoiding an immunostimulatory response and immunosuppressive c... |
|
|
Invention
|
Rna-coded antibody. The present application describes an antibody-coding, non-modified or modifie... |
|
2007
|
Invention
|
Method for purifying rna on a preparative scale by means of hplc. The application describes a met... |
|
|
Invention
|
Base-modified rna for increasing the expression of a protein.
The present application describes ... |
